People In The News: Astellas, Curis, Novavax Revise Exec Line-Ups
Executive Summary
Astellas promotes several in its commercial team and names new head of EMEA operations; veteran CDER official Jane Axelrad retiring; more personnel announcements in this month's column.
You may also be interested in...
'Brilliant' and 'Steady' Jenkins Retiring From US FDA's Office of New Drugs
Implementer of many drug review changes will leave in January after nearly 32 years of public service.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.